L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d

BackgroundHuntington's disease (HD) is a neurodegenerative disorder with wide-ranging effects on motor, cognitive and behavioural effects and a great impact on patient's health- related quality of life (HRQoL). HRQoL measures are increasingly used in clinical assessment to evaluate interve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2014-09, Vol.85 (Suppl 1), p.A92-A93
Hauptverfasser: Hernandez, B, Trigo, P, Garcia de Yebenes, J, Clay, E, Toumi, M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A93
container_issue Suppl 1
container_start_page A92
container_title Journal of neurology, neurosurgery and psychiatry
container_volume 85
creator Hernandez, B
Trigo, P
Garcia de Yebenes, J
Clay, E
Toumi, M
description BackgroundHuntington's disease (HD) is a neurodegenerative disorder with wide-ranging effects on motor, cognitive and behavioural effects and a great impact on patient's health- related quality of life (HRQoL). HRQoL measures are increasingly used in clinical assessment to evaluate intervention effectiveness. Such assessments allow decision makers to consider patient and caregiver perspectives.AimsThe aim of the study was to evaluate the HRQoL of Spanish HD patients and to compare results provided by EQ-5D and H-QoL-I instruments.MethodsThis was an observational, cross-sectional study conducted in Spain on the burden of disease (BoD) and HRQoL of HD patients and caregivers. HD Patients were recruited through a neurologist in a clinical setting. Several clinical, functional, BoD and HRQoL measures were collected (we present only HRQoL data). The EuroQOL five dimensions questionnaire (EQ-5D) and Huntington Quality of Life Instrument (H-QoL-I: a new validated HD specific HRQoL scale) were voluntarily self-completed. Pearson's correlation tests were computed.Results55 patients were recruited. The mean plus or minus SD age was 50 plus or minus 14 years. 51% were female. Results from H-QoL-I indicated that the psychological dimension was the most altered dimension, slightly greater than the motor dimension (scores: 58.06 and 56.96 respectively) whereas social dimension was not altered (score 80.93). Usual activities and anxiety/depression were the most altered dimensions based on the EQ-5D whereas pain was the least altered dimension. All Pearson's correlations between the H-QoL-I and EQ-5D were statistically significant (p < 0.01).ConclusionThe quality of life of the Spanish HD patients included in this study was seriously affected by the disease. Motor and psychological dimensions were the most affected whereas pain and social dimensions were less affected. Better therapeutic options to improve motor function, and hence, HRQoL are needed.
doi_str_mv 10.1136/jnnp-2014-309032.268
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808616937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808616937</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_18086169373</originalsourceid><addsrcrecordid>eNqVir1OwzAURj2A1PLzBgx3g8Xl2m5DMiIo6lAEiEodK6u5Ia7MTdJrD7w9rdQX6Dd8Rzo6St0ZnBjjiscdc68tmql2WKGzE1uUF2qMaO3BzHCkrkR2eFxZjVW9dGbVEnxlH0P6g48GlqGhI797z0Fa-PQpECeBdUgtLDKnwD-p43uB1yDkheD98HlP9SnRQxd1gGeuYT7oWX2jLhsfhW5PvFYPb_PVy0L3-27IJGnzG2RLMXqmLsvGlFgWpqjckzsj_Qcg0U2N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808616937</pqid></control><display><type>article</type><title>L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d</title><source>BMJ Journals - NESLi2</source><creator>Hernandez, B ; Trigo, P ; Garcia de Yebenes, J ; Clay, E ; Toumi, M</creator><creatorcontrib>Hernandez, B ; Trigo, P ; Garcia de Yebenes, J ; Clay, E ; Toumi, M</creatorcontrib><description>BackgroundHuntington's disease (HD) is a neurodegenerative disorder with wide-ranging effects on motor, cognitive and behavioural effects and a great impact on patient's health- related quality of life (HRQoL). HRQoL measures are increasingly used in clinical assessment to evaluate intervention effectiveness. Such assessments allow decision makers to consider patient and caregiver perspectives.AimsThe aim of the study was to evaluate the HRQoL of Spanish HD patients and to compare results provided by EQ-5D and H-QoL-I instruments.MethodsThis was an observational, cross-sectional study conducted in Spain on the burden of disease (BoD) and HRQoL of HD patients and caregivers. HD Patients were recruited through a neurologist in a clinical setting. Several clinical, functional, BoD and HRQoL measures were collected (we present only HRQoL data). The EuroQOL five dimensions questionnaire (EQ-5D) and Huntington Quality of Life Instrument (H-QoL-I: a new validated HD specific HRQoL scale) were voluntarily self-completed. Pearson's correlation tests were computed.Results55 patients were recruited. The mean plus or minus SD age was 50 plus or minus 14 years. 51% were female. Results from H-QoL-I indicated that the psychological dimension was the most altered dimension, slightly greater than the motor dimension (scores: 58.06 and 56.96 respectively) whereas social dimension was not altered (score 80.93). Usual activities and anxiety/depression were the most altered dimensions based on the EQ-5D whereas pain was the least altered dimension. All Pearson's correlations between the H-QoL-I and EQ-5D were statistically significant (p &lt; 0.01).ConclusionThe quality of life of the Spanish HD patients included in this study was seriously affected by the disease. Motor and psychological dimensions were the most affected whereas pain and social dimensions were less affected. Better therapeutic options to improve motor function, and hence, HRQoL are needed.</description><identifier>ISSN: 0022-3050</identifier><identifier>DOI: 10.1136/jnnp-2014-309032.268</identifier><language>eng</language><ispartof>Journal of neurology, neurosurgery and psychiatry, 2014-09, Vol.85 (Suppl 1), p.A92-A93</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hernandez, B</creatorcontrib><creatorcontrib>Trigo, P</creatorcontrib><creatorcontrib>Garcia de Yebenes, J</creatorcontrib><creatorcontrib>Clay, E</creatorcontrib><creatorcontrib>Toumi, M</creatorcontrib><title>L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d</title><title>Journal of neurology, neurosurgery and psychiatry</title><description>BackgroundHuntington's disease (HD) is a neurodegenerative disorder with wide-ranging effects on motor, cognitive and behavioural effects and a great impact on patient's health- related quality of life (HRQoL). HRQoL measures are increasingly used in clinical assessment to evaluate intervention effectiveness. Such assessments allow decision makers to consider patient and caregiver perspectives.AimsThe aim of the study was to evaluate the HRQoL of Spanish HD patients and to compare results provided by EQ-5D and H-QoL-I instruments.MethodsThis was an observational, cross-sectional study conducted in Spain on the burden of disease (BoD) and HRQoL of HD patients and caregivers. HD Patients were recruited through a neurologist in a clinical setting. Several clinical, functional, BoD and HRQoL measures were collected (we present only HRQoL data). The EuroQOL five dimensions questionnaire (EQ-5D) and Huntington Quality of Life Instrument (H-QoL-I: a new validated HD specific HRQoL scale) were voluntarily self-completed. Pearson's correlation tests were computed.Results55 patients were recruited. The mean plus or minus SD age was 50 plus or minus 14 years. 51% were female. Results from H-QoL-I indicated that the psychological dimension was the most altered dimension, slightly greater than the motor dimension (scores: 58.06 and 56.96 respectively) whereas social dimension was not altered (score 80.93). Usual activities and anxiety/depression were the most altered dimensions based on the EQ-5D whereas pain was the least altered dimension. All Pearson's correlations between the H-QoL-I and EQ-5D were statistically significant (p &lt; 0.01).ConclusionThe quality of life of the Spanish HD patients included in this study was seriously affected by the disease. Motor and psychological dimensions were the most affected whereas pain and social dimensions were less affected. Better therapeutic options to improve motor function, and hence, HRQoL are needed.</description><issn>0022-3050</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqVir1OwzAURj2A1PLzBgx3g8Xl2m5DMiIo6lAEiEodK6u5Ia7MTdJrD7w9rdQX6Dd8Rzo6St0ZnBjjiscdc68tmql2WKGzE1uUF2qMaO3BzHCkrkR2eFxZjVW9dGbVEnxlH0P6g48GlqGhI797z0Fa-PQpECeBdUgtLDKnwD-p43uB1yDkheD98HlP9SnRQxd1gGeuYT7oWX2jLhsfhW5PvFYPb_PVy0L3-27IJGnzG2RLMXqmLsvGlFgWpqjckzsj_Qcg0U2N</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Hernandez, B</creator><creator>Trigo, P</creator><creator>Garcia de Yebenes, J</creator><creator>Clay, E</creator><creator>Toumi, M</creator><scope>7TK</scope></search><sort><creationdate>20140901</creationdate><title>L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d</title><author>Hernandez, B ; Trigo, P ; Garcia de Yebenes, J ; Clay, E ; Toumi, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_18086169373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernandez, B</creatorcontrib><creatorcontrib>Trigo, P</creatorcontrib><creatorcontrib>Garcia de Yebenes, J</creatorcontrib><creatorcontrib>Clay, E</creatorcontrib><creatorcontrib>Toumi, M</creatorcontrib><collection>Neurosciences Abstracts</collection><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernandez, B</au><au>Trigo, P</au><au>Garcia de Yebenes, J</au><au>Clay, E</au><au>Toumi, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d</atitle><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle><date>2014-09-01</date><risdate>2014</risdate><volume>85</volume><issue>Suppl 1</issue><spage>A92</spage><epage>A93</epage><pages>A92-A93</pages><issn>0022-3050</issn><abstract>BackgroundHuntington's disease (HD) is a neurodegenerative disorder with wide-ranging effects on motor, cognitive and behavioural effects and a great impact on patient's health- related quality of life (HRQoL). HRQoL measures are increasingly used in clinical assessment to evaluate intervention effectiveness. Such assessments allow decision makers to consider patient and caregiver perspectives.AimsThe aim of the study was to evaluate the HRQoL of Spanish HD patients and to compare results provided by EQ-5D and H-QoL-I instruments.MethodsThis was an observational, cross-sectional study conducted in Spain on the burden of disease (BoD) and HRQoL of HD patients and caregivers. HD Patients were recruited through a neurologist in a clinical setting. Several clinical, functional, BoD and HRQoL measures were collected (we present only HRQoL data). The EuroQOL five dimensions questionnaire (EQ-5D) and Huntington Quality of Life Instrument (H-QoL-I: a new validated HD specific HRQoL scale) were voluntarily self-completed. Pearson's correlation tests were computed.Results55 patients were recruited. The mean plus or minus SD age was 50 plus or minus 14 years. 51% were female. Results from H-QoL-I indicated that the psychological dimension was the most altered dimension, slightly greater than the motor dimension (scores: 58.06 and 56.96 respectively) whereas social dimension was not altered (score 80.93). Usual activities and anxiety/depression were the most altered dimensions based on the EQ-5D whereas pain was the least altered dimension. All Pearson's correlations between the H-QoL-I and EQ-5D were statistically significant (p &lt; 0.01).ConclusionThe quality of life of the Spanish HD patients included in this study was seriously affected by the disease. Motor and psychological dimensions were the most affected whereas pain and social dimensions were less affected. Better therapeutic options to improve motor function, and hence, HRQoL are needed.</abstract><doi>10.1136/jnnp-2014-309032.268</doi></addata></record>
fulltext fulltext
identifier ISSN: 0022-3050
ispartof Journal of neurology, neurosurgery and psychiatry, 2014-09, Vol.85 (Suppl 1), p.A92-A93
issn 0022-3050
language eng
recordid cdi_proquest_miscellaneous_1808616937
source BMJ Journals - NESLi2
title L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T17%3A20%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L31The%20Quality%20Of%20Life%20Of%20Spanish%20Patients%20With%20Huntington's%20Disease%20Measured%20With%20H-qol-i%20And%20Eq-5d&rft.jtitle=Journal%20of%20neurology,%20neurosurgery%20and%20psychiatry&rft.au=Hernandez,%20B&rft.date=2014-09-01&rft.volume=85&rft.issue=Suppl%201&rft.spage=A92&rft.epage=A93&rft.pages=A92-A93&rft.issn=0022-3050&rft_id=info:doi/10.1136/jnnp-2014-309032.268&rft_dat=%3Cproquest%3E1808616937%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808616937&rft_id=info:pmid/&rfr_iscdi=true